Contamination susceptibility of three needleless and one standard needle injection systems

Canadian Journal of Anaesthesia

Volumn 46, Issue 3, 1999, Pages 290-293

  Ho, Anthony M H ^a,b,c,d   Ling, Elizabeth ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Can Anaesthetists' Soc Annual M   (Canada)

^d Phys Serv' Incorporated Foundation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; INJECTION; NEEDLE; PRIORITY JOURNAL;

EID: 0032894822     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03012613     Document Type: Article

References (11)

1. Marcus R and the CDC Cooperative Needlestick Surveillance Group. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiencey virus. N Engl J Med 1988; 319: 1118-23.
2. Berry AJ, Greene ES. The risk of needlestick injuries and needlestick-transmitted diseases in the practice of anesthesiology. Anesthesiology 1992; 77: 1007-21.
3. Greene ES, Berry AJ, Arnold WP III, Jagger J. Percutaneous injuries in anesthesia personnel. Anesth Analg 1996; 83: 273-8.
4. Gerberding JL. Current epidemiologic evidence and case reports of occupationally acquired HIV and other bloodborne diseases. Infect Control Hosp Epidemiol 1990; 11: 558-60.
5. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control 1995; 23: 273-7.
6. Armstrong SE. The cost of needle-stick injuries: the impact of safer medical devices. Nursing Economy 1991; 9: 426-30, 433.
7. Maki DG, Weise CE, Sarafin HW. A semiquantitive culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296: 1305-9.
8. Tager TB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983; 118: 839-51.
9. Bostrom-Ezrati J, Dibble S, Rizzuto C. Intravenous therapy management: who will develop insertion site symptoms? Appl Nurs Res 1990; 3: 146-52.
10. Adams KS, Zehrer CL, Thomas W. Comparison of a needleless system with conventional heparin locks. Am J Infect Control 1993; 21: 263-9.
11. Larson EL, Cheng G, Choo JTE, Merz W. In vitro survival of skin flora in heparin locks and needleless valve infusion devices. Heart Lung 1993; 22: 459-62.